Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment

L.A. Devriese, P.O. Witteveen, S. Marchetti, M. Mergui-Roelvink, L. Reyderman, J. Wanders, A. Jenner, G. Edwards, J.H. Beijnen, E.E. Voest, J.H.M. Schellens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)823-832
Number of pages10
JournalCancer Chemotherapy and Pharmacology
Volume70
DOIs
Publication statusPublished - 2012

Cite this